Cargando…

Factors influencing diagnosis and treatment initiation for multidrug-resistant/rifampicin-resistant tuberculosis in six sub-Saharan African countries: a mixed-methods systematic review

BACKGROUND: Drug-resistant tuberculosis burdens fragile health systems in sub-Saharan Africa (SSA), complicated by high prevalence of HIV. Several African countries reported large gaps between estimated incidence and diagnosed or treated cases. Our review aimed to identify barriers and facilitators...

Descripción completa

Detalles Bibliográficos
Autores principales: Oga-Omenka, Charity, Tseja-Akinrin, Azhee, Sen, Paulami, Mac-Seing, Muriel, Agbaje, Aderonke, Menzies, Dick, Zarowsky, Christina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7333807/
https://www.ncbi.nlm.nih.gov/pubmed/32616481
http://dx.doi.org/10.1136/bmjgh-2019-002280
_version_ 1783553823000756224
author Oga-Omenka, Charity
Tseja-Akinrin, Azhee
Sen, Paulami
Mac-Seing, Muriel
Agbaje, Aderonke
Menzies, Dick
Zarowsky, Christina
author_facet Oga-Omenka, Charity
Tseja-Akinrin, Azhee
Sen, Paulami
Mac-Seing, Muriel
Agbaje, Aderonke
Menzies, Dick
Zarowsky, Christina
author_sort Oga-Omenka, Charity
collection PubMed
description BACKGROUND: Drug-resistant tuberculosis burdens fragile health systems in sub-Saharan Africa (SSA), complicated by high prevalence of HIV. Several African countries reported large gaps between estimated incidence and diagnosed or treated cases. Our review aimed to identify barriers and facilitators influencing diagnosis and treatment for drug-resistant tuberculosis (DR-TB) in SSA, which is necessary to develop effective strategies to find the missing incident cases and improve quality of care. METHODS: Using an integrative design, we reviewed and narratively synthesised qualitative, quantitative and mixed-methods studies from nine electronic databases: Medline, Global Health, CINAHL, EMBASE, Scopus, Web of Science, International Journal of Tuberculosis and Lung Disease, PubMed and Google Scholar (January 2006 to June 2019). RESULTS: Of 3181 original studies identified, 55 full texts were screened, and 29 retained. The studies included were from 6 countries, mostly South Africa. Barriers and facilitators to DR-TB care were identified at the health system and patient levels. Predominant health system barriers were laboratory operational issues, provider knowledge and attitudes and information management. Facilitators included GeneXpert MTB/RIF (Xpert) diagnosis and decentralisation of services. At the patient level, predominant barriers were patients being lost to follow-up or dying due to lengthy diagnostic and treatment delays, negative public sector care perceptions, family, work or school commitments and using private sector care. Some patient-level facilitators were HIV positivity and having more symptoms. CONCLUSION: Case detection and treatment for DR -TB in SSA currently relies on individual patients presenting voluntarily to the hospital for care. Specific interventions targeting identified barriers may improve rates and timeliness of detection and treatment.
format Online
Article
Text
id pubmed-7333807
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-73338072020-07-07 Factors influencing diagnosis and treatment initiation for multidrug-resistant/rifampicin-resistant tuberculosis in six sub-Saharan African countries: a mixed-methods systematic review Oga-Omenka, Charity Tseja-Akinrin, Azhee Sen, Paulami Mac-Seing, Muriel Agbaje, Aderonke Menzies, Dick Zarowsky, Christina BMJ Glob Health Original Research BACKGROUND: Drug-resistant tuberculosis burdens fragile health systems in sub-Saharan Africa (SSA), complicated by high prevalence of HIV. Several African countries reported large gaps between estimated incidence and diagnosed or treated cases. Our review aimed to identify barriers and facilitators influencing diagnosis and treatment for drug-resistant tuberculosis (DR-TB) in SSA, which is necessary to develop effective strategies to find the missing incident cases and improve quality of care. METHODS: Using an integrative design, we reviewed and narratively synthesised qualitative, quantitative and mixed-methods studies from nine electronic databases: Medline, Global Health, CINAHL, EMBASE, Scopus, Web of Science, International Journal of Tuberculosis and Lung Disease, PubMed and Google Scholar (January 2006 to June 2019). RESULTS: Of 3181 original studies identified, 55 full texts were screened, and 29 retained. The studies included were from 6 countries, mostly South Africa. Barriers and facilitators to DR-TB care were identified at the health system and patient levels. Predominant health system barriers were laboratory operational issues, provider knowledge and attitudes and information management. Facilitators included GeneXpert MTB/RIF (Xpert) diagnosis and decentralisation of services. At the patient level, predominant barriers were patients being lost to follow-up or dying due to lengthy diagnostic and treatment delays, negative public sector care perceptions, family, work or school commitments and using private sector care. Some patient-level facilitators were HIV positivity and having more symptoms. CONCLUSION: Case detection and treatment for DR -TB in SSA currently relies on individual patients presenting voluntarily to the hospital for care. Specific interventions targeting identified barriers may improve rates and timeliness of detection and treatment. BMJ Publishing Group 2020-07-02 /pmc/articles/PMC7333807/ /pubmed/32616481 http://dx.doi.org/10.1136/bmjgh-2019-002280 Text en © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Original Research
Oga-Omenka, Charity
Tseja-Akinrin, Azhee
Sen, Paulami
Mac-Seing, Muriel
Agbaje, Aderonke
Menzies, Dick
Zarowsky, Christina
Factors influencing diagnosis and treatment initiation for multidrug-resistant/rifampicin-resistant tuberculosis in six sub-Saharan African countries: a mixed-methods systematic review
title Factors influencing diagnosis and treatment initiation for multidrug-resistant/rifampicin-resistant tuberculosis in six sub-Saharan African countries: a mixed-methods systematic review
title_full Factors influencing diagnosis and treatment initiation for multidrug-resistant/rifampicin-resistant tuberculosis in six sub-Saharan African countries: a mixed-methods systematic review
title_fullStr Factors influencing diagnosis and treatment initiation for multidrug-resistant/rifampicin-resistant tuberculosis in six sub-Saharan African countries: a mixed-methods systematic review
title_full_unstemmed Factors influencing diagnosis and treatment initiation for multidrug-resistant/rifampicin-resistant tuberculosis in six sub-Saharan African countries: a mixed-methods systematic review
title_short Factors influencing diagnosis and treatment initiation for multidrug-resistant/rifampicin-resistant tuberculosis in six sub-Saharan African countries: a mixed-methods systematic review
title_sort factors influencing diagnosis and treatment initiation for multidrug-resistant/rifampicin-resistant tuberculosis in six sub-saharan african countries: a mixed-methods systematic review
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7333807/
https://www.ncbi.nlm.nih.gov/pubmed/32616481
http://dx.doi.org/10.1136/bmjgh-2019-002280
work_keys_str_mv AT ogaomenkacharity factorsinfluencingdiagnosisandtreatmentinitiationformultidrugresistantrifampicinresistanttuberculosisinsixsubsaharanafricancountriesamixedmethodssystematicreview
AT tsejaakinrinazhee factorsinfluencingdiagnosisandtreatmentinitiationformultidrugresistantrifampicinresistanttuberculosisinsixsubsaharanafricancountriesamixedmethodssystematicreview
AT senpaulami factorsinfluencingdiagnosisandtreatmentinitiationformultidrugresistantrifampicinresistanttuberculosisinsixsubsaharanafricancountriesamixedmethodssystematicreview
AT macseingmuriel factorsinfluencingdiagnosisandtreatmentinitiationformultidrugresistantrifampicinresistanttuberculosisinsixsubsaharanafricancountriesamixedmethodssystematicreview
AT agbajeaderonke factorsinfluencingdiagnosisandtreatmentinitiationformultidrugresistantrifampicinresistanttuberculosisinsixsubsaharanafricancountriesamixedmethodssystematicreview
AT menziesdick factorsinfluencingdiagnosisandtreatmentinitiationformultidrugresistantrifampicinresistanttuberculosisinsixsubsaharanafricancountriesamixedmethodssystematicreview
AT zarowskychristina factorsinfluencingdiagnosisandtreatmentinitiationformultidrugresistantrifampicinresistanttuberculosisinsixsubsaharanafricancountriesamixedmethodssystematicreview